Angiotensin-converting enzyme (ACE) inhibitors for coronary artery disease
Examples
| benazepril hydrochloride |
Lotensin
|
| captopril |
Capoten
|
| enalapril maleate |
Vasotec
|
| fosinopril sodium |
Monopril
|
| lisinopril |
Prinivil,
Zestoretic,
Zestril,
|
| perindopril |
Aceon
|
| quinapril hydrochloride |
Accupril
|
| ramipril |
Altace
|
| trandolapril |
Mavik
|
How It Works
Angiotensin-converting enzyme (ACE)
inhibitors interfere with the formation of a hormone (angiotensin II) that can
narrow (constrict) blood vessels. ACE inhibitors help lower blood pressure and
reduce the workload on the heart, which lowers the chances of
heart attack
.
Why It Is Used
ACE inhibitors are recommended for
people who have coronary artery disease, particularly those who also have
diabetes. Also, if an ACE inhibitor is not already used, it is usually
prescribed immediately after a heart attack. Studies have shown that ACE
inhibitors save lives and reduce the risk of heart attack and stroke in people
with CAD.
1
These drugs frequently are also used to
treat
high blood pressure
and
heart failure
.
How Well It Works
ACE inhibitors, if used within 24
hours of the start of heart attack symptoms, appear to reduce the risk of death
associated with the heart attack.
2
Use of ACE
inhibitors following a heart attack can also help prevent the development of
heart failure related to a heart attack.
The HOPE trial (the Heart
Outcomes Prevention Evaluation trial) concluded that ramipril (Altace) reduced
the rate of death, heart attack, and
stroke
in people who were at high risk for these
problems but who did not have any signs of heart failure or other abnormal
heart function. This study suggests that, in addition to people who already
have known abnormal heart function or heart failure, people at high risk for a
heart attack or sudden death from
coronary artery disease
also may benefit from taking
ramipril.
3
A similar study conducted in
Europe (the EUROPA study) found a similar benefit from perindopril (Aceon) in
people with a moderate to high risk of a heart attack or sudden death from
coronary artery disease. However, the EUROPA study showed the benefit is not
apparent until the medicine has been taken for 1 year or longer.
4
Side Effects
Side effects may include:
-
Cough. A cough is one of the most common side
effects of ACE inhibitors. Most people find the cough to be a minor problem
that they can tolerate in exchange for the benefits of this medicine. If
coughing is a severe problem, other medicines can be tried.
-
Low blood pressure. Another side effect of ACE
inhibitors may be low blood pressure, which may cause symptoms of dizziness,
weakness, or fainting. People with low to normal blood pressure generally will
be started on a low dose of medicine and need to have their blood pressure
monitored regularly.
-
Swelling. Swelling in the face, neck, lips, throat,
hands, feet, or genitals rarely may occur when using ACE inhibitors. If
swelling affects the face or throat, it can interfere with breathing. If this
occurs, notify your doctor immediately.
-
High potassium levels. A high potassium level can
disrupt the normal electrical impulses in the heart, leading to irregular
heartbeats (arrhythmias). Potassium levels are monitored with blood
tests.
See Drug Reference for a full list of side effects.
(Drug Reference is not available in all systems.)
What To Think About
If you are pregnant or may
become pregnant, do not take ACE inhibitors.
Usually, ACE
inhibitors cause very few side effects. The most common side effect is an
irritating dry cough. Most people find the cough to be a minor problem that
they can live with in exchange for the benefits of this medicine. If you take
an ACE inhibitor and have a problem with coughing, then you might take an
angiotensin II receptor blocker (ARB) instead. ARBs are less likely to cause a
cough.
Complete the
new medication information form (PDF)
(What is a
PDF
document?)
to help you understand this medication.
References
Citations
-
Snow V, et al. (2004). Primary care management of
chronic stable angina and asymptomatic suspected or known coronary artery
disease: A clinical practice guideline from the American College of Physicians.
Annals of Internal Medicine, 141(7): 562–567. Also
available online: http://www.annals.org/cgi/reprint/141/7/562.pdf.
-
Danchin N, Durand E (2006). Acute myocardial
infarction, search date August 2004. Online version of BMJ Clinical Evidence. Also available online:
http://www.clinicalevidence.com.
-
Heart Outcomes Prevention
Evaluation Study (HOPE) Investigators (2000). Effects of an angiotensin-converting enzyme
inhibitor, ramipril, on cardiovascular events in high-risk patients. New England Journal of Medicine, 342(3): 145–153.
-
Fox KM (2003). Efficacy of perindopril in reduction of
cardiovascular events among patients with stable coronary artery disease:
Randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA
study). Lancet: 362(9386): 782–788.
Last Updated:May 29, 2008
Snow V, et al. (2004). Primary care management of
chronic stable angina and asymptomatic suspected or known coronary artery
disease: A clinical practice guideline from the American College of Physicians.
Annals of Internal Medicine, 141(7): 562–567. Also
available online: http://www.annals.org/cgi/reprint/141/7/562.pdf.
Danchin N, Durand E (2006). Acute myocardial
infarction, search date August 2004. Online version of BMJ Clinical Evidence. Also available online:
http://www.clinicalevidence.com.
Heart Outcomes Prevention
Evaluation Study (HOPE) Investigators (2000). Effects of an angiotensin-converting enzyme
inhibitor, ramipril, on cardiovascular events in high-risk patients. New England Journal of Medicine, 342(3): 145–153.
Fox KM (2003). Efficacy of perindopril in reduction of
cardiovascular events among patients with stable coronary artery disease:
Randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA
study). Lancet: 362(9386): 782–788.